Limited Utility of Routine Surveillance Ultrasound in Differentiated Thyroid Cancer Patients With Undetectable Postoperative Thyroglobulin Levels
Clinical Endocrinology · 2025
DOI: 10.1111/cen.15198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Young-Ji Seo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrine Surgery, Department of Surgery, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Thyroglobulin, Thyroid Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Neck ultrasound (US) and serum thyroglobulin (Tg) measurements are mainstays of long‐term differentiated thyroid cancer (DTC) surveillance. Given the high sensitivity of serum Tg, we aimed to assess the utility of neck US in DTC patients who underwent total thyroidectomy and have undetectable serum Tg.
Methods
We performed a retrospective cohort analysis of DTC patients who underwent a total thyroidectomy at our institution (2010–2023) and received US‐guided fine needle aspiration (FNA) during their surveillance. Patients were categorised into three lab categories based on serum Tg and Tg antibody (Tg Ab) status before the biopsy: (1) ‘Negative Tg' if undetectable Tg ( < 0.2 ng/dL) and Tg Ab, (2) 'Positive Tg' if detectable Tg and undetectable Tg Ab, and (3) 'Positive Tg Ab' if detectable Tg Ab. To calculate the positive predictive value (PPV) of neck US, we defined the 'true positive' of US as findings that prompted an FNA biopsy resulting with DTC, and 'false positive' findings prompting an FNA biopsy that did not result as DTC.
Results
A total of 118 patients were included, encompassing 146 FNA biopsies: 33 (23%) had Negative Tg, 84 (57%) had Positive Tg, and 29 (20%) had Positive Tg Ab lab results before their biopsies. The PPV of neck US in the setting of Negative Tg was 3% (one true positive, 32 false positives), while the PPV was 50% (42 true positives, 42 false positives) for Positive Tg, and 52% (15 true positives, 14 false positives) for Positive Tg Ab cohorts. Sub‐analysis of the Positive Tg cohort using different serum Tg level cutoffs revealed a PPV of 29% at just detectable serum Tg of 0.2 ng/dL, and PPV of 38% for Tg < 1.0 ng/dL. The PPV stabilised at 58% for Tg levels ≥ 1 ng/dL.
Conclusion
With the low PPV of neck US, high cost of surveillance, and the advent of ultra‐sensitive serum Tg measurements, future guidelines should consider reducing routine neck US surveillance in patients with undetectable serum Tg and only performing it when there is a rise in serum Tg levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrine Surgery, Department of Surgery, University of California, Los Angeles, California, USA.
- David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- University of California, Los Angeles, Los Angeles, California, USA.
- Department of Medicine, University of California, Los Angeles, California, USA.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Seo, Y. J., Tiu, R., Stahl, K., Hughes, E., Tseng, C. H., Yeh, M., Livhits, M., & Wu, J. X. (2025). Limited Utility of Routine Surveillance Ultrasound in Differentiated Thyroid Cancer Patients With Undetectable Postoperative Thyroglobulin Levels. Clinical Endocrinology. https://doi.org/10.1111/cen.15198
Vancouver
Seo YJ, Tiu R, Stahl K, Hughes E, Tseng CH, Yeh M, et al. Limited Utility of Routine Surveillance Ultrasound in Differentiated Thyroid Cancer Patients With Undetectable Postoperative Thyroglobulin Levels. Clinical Endocrinology. 2025. doi:10.1111/cen.15198
BibTeX
@article{Seo2025,
author = {Seo, Young-Ji and Tiu, Ryan and Stahl, Katharina and Hughes, Elena and Tseng, Chi-Hong and Yeh, Michael and Livhits, Masha and Wu, James X},
title = {Limited Utility of Routine Surveillance Ultrasound in Differentiated Thyroid Cancer Patients With Undetectable Postoperative Thyroglobulin Levels},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15198}
}
EUVIMED